106 related articles for article (PubMed ID: 11342900)
1. Macroscopic, microscopic and molecular observations of bladder cancer.
Rowland RG
J Urol; 2001 May; 165(5):1480. PubMed ID: 11342900
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
[TBL] [Abstract][Full Text] [Related]
3. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology advances and perspectives in urology].
Feria Bernal G; Arroyo Kuribreña JC
Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
[No Abstract] [Full Text] [Related]
5. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new bladder tumor marker.
Grossman HB; Liebert M; Sakakibara N; Wedemeyer GA; Stein JA; Washington RW
Urol Clin North Am; 1991 Aug; 18(3):509-13. PubMed ID: 1877113
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-1 and -2 in human breast cancer.
Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K
Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950
[TBL] [Abstract][Full Text] [Related]
8. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.
O'Byrne KJ; Edwards JG; Waller DA
Lung Cancer; 2004 Aug; 45 Suppl 1():S45-8. PubMed ID: 15261433
[TBL] [Abstract][Full Text] [Related]
12. [Urinary tumor marker for urothelial cancer].
Ohtani M; Iwasaki A; Shiraiwa H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic role and regulation of cyclooxygenase-2 (COX-2) in ovarian carcinoma].
Denkert C
Zentralbl Gynakol; 2004 Oct; 126(5):326-7. PubMed ID: 15478052
[No Abstract] [Full Text] [Related]
14. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
15. Comparison of seven screening methods in the diagnosis of bladder cancer.
Sun Y; He DL; Ma Q; Wan XY; Zhu GD; Li L; Luo Y; He H; Yang L
Chin Med J (Engl); 2006 Nov; 119(21):1763-71. PubMed ID: 17097029
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.
Mohammed SI; Knapp DW; Bostwick DG; Foster RS; Khan KN; Masferrer JL; Woerner BM; Snyder PW; Koki AT
Cancer Res; 1999 Nov; 59(22):5647-50. PubMed ID: 10582676
[TBL] [Abstract][Full Text] [Related]
17. Ancillary methods for the detection of recurrent urothelial neoplasia.
Ross JS; Cohen MB
Cancer; 2000 Apr; 90(2):75-86. PubMed ID: 10794156
[No Abstract] [Full Text] [Related]
18. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
[TBL] [Abstract][Full Text] [Related]
20. [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].
Fukui Y; Samma S; Fujimoto K; Akiyama T; Yamaguchi A; Hirayama A
Hinyokika Kiyo; 2001 May; 47(5):311-4. PubMed ID: 11433750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]